Zymeworks (ZYME) Amortizatization of Intangibles (2021 - 2026)
Zymeworks recorded quarterly Amortizatization of Intangibles of $176000.0 in Q1 2026, down 80.95% quarter-over-quarter from $924000.0 in Q4 2025, and down 75.11% year-over-year from $707000.0 in Q1 2025.
Zymeworks' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $176000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 75.11% year-over-year to $176000.0; the TTM figure through Mar 2026 stood at $2.9 million (down 36.59% YoY), while the FY2025 annual figure was $3.4 million, down 24.71% from the prior year.
- Amortizatization of Intangibles came in at $176000.0 for Q1 2026 at Zymeworks, down from $924000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.9 million in Q1 2022 to a low of $176000.0 in Q1 2026.
- A 5-year average of $913411.8 and a median of $707000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles soared 231.75% in 2022 and slumped 77.77% in 2023, its largest moves.
- Zymeworks' Amortizatization of Intangibles stood at $627000.0 in 2022, then rose by 7.34% to $673000.0 in 2023, then soared by 197.47% to $2.0 million in 2024, then slumped by 53.85% to $924000.0 in 2025, then plunged by 80.95% to $176000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $176000.0, $924000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 176,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 176,000.00 |
| Mar 31, 2026 | 176,000.00 |
| Dec 31, 2025 | 924,000.00 |
| Dec 31, 2025 | 924,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 723,000.00 |
| Jun 30, 2025 | 723,000.00 |
| Mar 31, 2025 | 707,000.00 |
| Mar 31, 2025 | 707,000.00 |
| Dec 31, 2024 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 980,000.00 |
| Sep 30, 2024 | 980,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 702,000.00 |
| Mar 31, 2024 | 702,000.00 |
| Dec 31, 2023 | 673,000.00 |
| Dec 31, 2023 | 673,000.00 |
| Sep 30, 2023 | 672,000.00 |
| Sep 30, 2023 | 672,000.00 |
| Jun 30, 2023 | 720,000.00 |
| Jun 30, 2023 | 720,000.00 |
| Mar 31, 2023 | 637,000.00 |
| Mar 31, 2023 | 637,000.00 |
| Dec 31, 2022 | 627,000.00 |
| Dec 31, 2022 | 627,000.00 |
| Sep 30, 2022 | 642,000.00 |
| Sep 30, 2022 | 642,000.00 |
| Jun 30, 2022 | 635,000.00 |
| Jun 30, 2022 | 635,000.00 |
| Mar 31, 2022 | 2.87 Mn |
| Mar 31, 2022 | 2.87 Mn |
| Dec 31, 2021 | 189,000.00 |
| Dec 31, 2021 | 189,000.00 |